Literature DB >> 10457037

Helicobacter pylori-reflections for the next millennium.

G N Tytgat1.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10457037      PMCID： PMC1766653          DOI： 10.1136/gut.45.2008.i45

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients.

Authors:  K E McColl; A el-Nujumi; L Murray; E el-Omar; D Gillen; A Dickson; A Kelman; T E Hilditch
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.

Authors:  F K Chan; J J Sung; S C Chung; K F To; M Y Yung; V K Leung; Y T Lee; C S Chan; E K Li; J Woo
Journal:  Lancet       Date:  1997-10-04       Impact factor: 79.321

3.  Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood.

Authors:  R Roosendaal; E J Kuipers; J Buitenwerf; C van Uffelen; S G Meuwissen; G J van Kamp; C M Vandenbroucke-Grauls
Journal:  Am J Gastroenterol       Date:  1997-09       Impact factor: 10.864

Review 4.  Long-term consequences of Helicobacter pylori eradication: clinical aspects.

Authors:  J Labenz; B Tillenburg; U Peitz; G Börsch
Journal:  Scand J Gastroenterol Suppl       Date:  1996

5.  Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?

Authors:  S Jyotheeswaran; A N Shah; H O Jin; G D Potter; F V Ona; W Y Chey
Journal:  Am J Gastroenterol       Date:  1998-04       Impact factor: 10.864

Review 6.  Helicobacter pylori eradication and its implications for the future.

Authors:  M J Blaser
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

7.  Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

Authors:  C J Hawkey; J A Karrasch; L Szczepañski; D G Walker; A Barkun; A J Swannell; N D Yeomans
Journal:  N Engl J Med       Date:  1998-03-12       Impact factor: 91.245

8.  Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland.

Authors:  T U Kosunen; A Aromaa; P Knekt; A Salomaa; H Rautelin; P Lohi; O P Heinonen
Journal:  Epidemiol Infect       Date:  1997-08       Impact factor: 2.451

9.  The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease.

Authors:  J J Vicari; R M Peek; G W Falk; J R Goldblum; K A Easley; J Schnell; G I Perez-Perez; S A Halter; T W Rice; M J Blaser; J E Richter
Journal:  Gastroenterology       Date:  1998-07       Impact factor: 22.682

10.  The cohort effect and Helicobacter pylori.

Authors:  N Banatvala; K Mayo; F Megraud; R Jennings; J J Deeks; R A Feldman
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226
  10 in total
  1 in total

Review 1.  Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.